An Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES) May 27, 2020checkorphan Learn more about: Goodpasture syndrome Related Clinical Trial A Study With Imlifidase in Anti-GBM Disease An Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES) Recruitment InformationAdministrative Informations
